[kml_flashembed movie="http://ascension-publishing.com/GEN-2012-Fit.swf?clickTAG=http://bit.ly/bZlv8g" width="728" height="90"]

Tag: AMRS

Time is king for renewable fuels, in the Valley of Disbelief

Is there a bump for renewable fuels equities when they cross the “2 years to profitability” mark? We look beyond the Valley of Death and into the Valley of Disbelief. In Biofuels Digest this week, we introduced the idea that, after negotiating the Valley of Death, high-tech (including biofuels companies) enter the Valley of Disbelief, [...]

May 22, 2013 More

Amyris reports loss of $32.6M on sales of $7.9M for Q1 2013

In California, Amyris reported revenues for Q1 2013 of $7.9 million, and a net loss of $32.6 million ($0.44 per share) compared to a loss of $94.5 million ($1.88 per share) in the comparable quarter of 2012. The Company’s balance of cash, cash equivalents and marketable securities at the end of the first quarter was [...]

May 1, 2013 More

Gevo, Amyris, Solazyme — when will the fog lift for investors?

GEVO, SZYM, AMRS — (investor) take off delayed by fog. How soon will the potential of three of the hottest companies in the field be realized? What are the key milestones coming up for the industrial biotech’s Gold Dust Triplets? In Colorado, Gevo reported its Q4 and full-year 2012 results this week — and now [...]

March 6, 2013 More

Earnings season: Heading to the Biobased Scorecard

Earnings season is upon us — time to go, as they say, to the scoreboard for an update on some of the sector’s perennial favorites. GPRE earning, DSM acquiring, AMRS shipping — some welcome pars, even a birdie or two, from the front-lines. Now, the ethanol sector has been going through one of its periodic [...]

February 20, 2013 More